(PharmaNewsWire.Com, June 04, 2025 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” Generative AI GenAI in Digital Health Market– (By Deployment (Cloud-based, On-premises, Hybrid, Edge Computing), By Technology – Natural Language Processing (NLP), Machine Learning (ML), Predictive Analytics, Deep Learning (DL)), By Application (Drug Discovery and Development, Virtual Health Assistants, Personalized Medicine, Diagnostic Tools and Imaging), By End-User (Hospitals and Clinics, Research Institutes, Pharmaceutical Companies, Diagnostic Centers)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Generative AI (GenAI) in Digital Health Market is valued at USD 1.6 Bn in 2024, and it is expected to reach USD 33.7 Bn by the year 2034, with a CAGR of 36.5% during the forecast period of 2025-2034.
Global Generative AI (GenAI) in Digital Health Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3039
Generative artificial intelligence (GenAI) has emerged as a game-changing technology in the digital health sector, revolutionizing the healthcare industry by enhancing both new and existing technologies, products, and services. Through the use of sophisticated algorithms, GenAI produces contextually relevant and realistic data, facilitating faster and more intelligent searches for medical codes.
This allows for previously unheard-of improvements in personalized medicine, diagnostics, and treatment planning. Applications of GenAI range from drug discovery to predictive analytics, among other areas of healthcare delivery.
Among the major GenAI in digital health market trends are the quick integration of GenAI and Machine Learning (ML) in wearable technology, remote patient monitoring, and telehealth solutions, in addition to the explosive growth of AI-powered diagnosis and treatment tools.
In addition, significant advancements in the healthcare industry have been made by integrating GenAI with Electronic Health Records (EHRs) to create thorough patient profiles and use Natural Language Processing (NLP) to enhance patient-doctor communication.
List of Prominent Players in the Generative AI (GenAI) in Digital Health Market:
• Siemens Healthineers
• Philips Healthcare
• Intel Corporation
• Tempus Labs
• PathAI
• Aidoc Medical
• Zebra Medical Vision
• NVIDIA Corporation
• Microsoft Corporation
• Google (Alphabet Inc.) – Google Health
• IBM Watson Health
• Butterfly Network
• Tempus
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics:
Drivers-
The GenAI in digital health market is going through a number of developments that are influencing its expansion. The sector is expanding due to a number of factors, including artificial intelligence developments, rising investment, and an emphasis on enhancing healthcare outcomes and efficiency.
Governments, businesses, and venture capitalists have also been investing heavily in generative AI (GenAI) in digital health technology to improve the effectiveness of healthcare. The National Institutes of Health (NIH). This significant investment has spurred innovation and market expansion by speeding up developments in AI-driven medication discovery and medical diagnostics.
Challenges:
Since the healthcare sector regularly generates enormous amounts of sensitive patient-related data and information, issues with data privacy and security present serious difficulties. The regulatory environment and compliance standards make integrating GenAI technologies even more challenging.
Additionally, healthcare systems lack standardized frameworks for data exchange and interoperability, which makes it difficult to integrate GenAI across many platforms. Additional obstacles to adoption include the high expenses of putting GenAI solutions into practice and the requirement that healthcare workers undergo intensive training.
Regional Trends:
The North American Generative AI (GenAI) in the Digital Health market is anticipated to register a major market share in terms of revenue. One of the most sophisticated healthcare systems in the world is found in North America, United States and Canada.
This comprises state-of-the-art medical facilities, research centres, and a strong network of clinics and hospitals implementing generative AI in digital health technologies to improve patient care, optimize resource management, and streamline operations.
A robust healthcare infrastructure supports the incorporation of AI tools and technology into routine medical practice. Additionally, the area is leading the way in healthcare’s digital transformation and technology readiness. Besides, over the projection period, Asia Pacific is expected to increase at the fastest rate.
By offering individualized diagnosis, therapies, and virtual care alternatives to handle the large patient load, generative AI in digital health plays a crucial role in meeting these demands. The region’s thriving startup scene is working hard to create generative AI tools and other AI-driven healthcare solutions.
Innovations in fields such as drug research, medical imaging, and virtual health aides have been fueled by substantial government and venture capital financing.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/3039
Recent Development:
• October 2024: Google Cloud and Citi established a strategic alliance to use Vertex AI’s generative AI capabilities to update Citi’s infrastructure with cloud and AI technologies. Through this partnership, Google Cloud’s market penetration and business growth are accelerated, its leadership in AI is reinforced, and its footprint in the financial industry is increased.
Segmentation of Generative AI (GenAI) in Digital Health Market-
By Deployment-
• Cloud-based
• On-premises
• Hybrid
• Edge Computing
By Technology-
• Natural Language Processing (NLP)
• Machine Learning (ML)
• Predictive Analytics
• Deep Learning (DL)
By Application-
• Drug Discovery and Development
• Virtual Health Assistants
• Personalized Medicine
• Diagnostic Tools and Imaging
By End-User-
• Hospitals and Clinics
• Research Institutes
• Pharmaceutical Companies
• Diagnostic Centers
By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/generative-ai-genai-in-digital-health-market/3039
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
Insight Ace Analytics
Diana D’souza
+1 551 226 6109
diana.dsouza@insightaceanalytics.com
Source: EmailWire.Com
Source link
